Patent · US Expired

Short amphipathic peptides with activity against bacteria and intracellular pathogens

US6566334B1 · kind B1 · utility

14Cited by
0References
39Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 5, 1998
Grant dateMay 20, 2003
Priority date
Expiry dateFeb 5, 2018

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S977/903
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

“Minimalist” antimicrobial peptides are disclosed based on 50 to 80% &agr;,&agr;-dialkylated amino acids. The peptides are short, cationic, amphipathic, and possess a high helix propensity. Polar &agr;,&agr;-dialkylated amino acids are also disclosed. These peptides are easy and inexpensive to synthesize via solid-phase techniques. The peptides exhibit in vitro anti-bacterial properties at concentrations that are not lethal to normal mammalian cells. The peptides exhibit in vivo bioactivity against intracellular pathogens.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.